Welcome to our dedicated page for Thermon Group Holdings SEC filings (Ticker: THR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Thermon Group Holdings, Inc. filings document an NYSE-listed operating company focused on industrial process heating and related engineered solutions. Recent Form 8-K reports cover operating and financial results, Regulation FD investor presentations, product and market updates for liquid load bank solutions, and material agreements tied to the company's credit arrangements.
The filings also disclose common stock registered on the New York Stock Exchange under THR, capital-structure matters, annual meeting voting results, director election and other governance matters, and exhibits such as earnings releases, investor presentations and press releases furnished with current reports.
Thermon Group Holdings (THR) reported stronger quarterly results. For the three months ended September 30, 2025, sales rose to $131.7 million from $114.6 million, with gross profit up to $61.1 million from $50.9 million. Net income increased to $15.0 million from $9.5 million, and diluted EPS was $0.45 versus $0.28. Segment sales were $63.8 million in US-LAM, $40.4 million in Canada, $18.1 million in EMEA, and $9.5 million in APAC.
Liquidity and capital structure shifted with a new Second Amended and Restated Credit Agreement on July 24, 2025, including a $115.0 million revolving credit facility and a $125.0 million term loan maturing July 24, 2030. At quarter-end, cash and cash equivalents were $29.7 million; revolving borrowings were $14.7 million with $99.4 million available, and term debt (net) was $124.3 million. Operating cash flow for the six months was $18.2 million. The company repurchased 236,427 shares for $6.0 million in the quarter and 601,125 shares for $15.8 million year-to-date. Backlog was $251.3 million, up from $240.3 million at March 31, 2025. As of November 5, 2025, 32,840,075 common shares were outstanding.
Thermon Group Holdings (THR) furnished a press release announcing its consolidated financial results for the second quarter of fiscal 2026. The company also posted an updated “Earnings Presentation (Second Quarter Fiscal 2026)” on its investor relations website on November 6, 2025.
The materials referenced under Items 2.02 and 7.01 are being furnished, not filed, which limits their applicability under Section 18 of the Exchange Act. An accompanying press release is included as Exhibit 99.1, with the presentation available at ir.thermon.com.
Thermon Group Holdings (THR) reported an insider transaction by its SVP, CFO. On November 1, 2025, 1,382 common shares were withheld (Transaction Code F) to cover taxes upon vesting of restricted stock units at a price of $28.73.
Following the transaction, the executive directly owned 21,728 shares. The filing notes the sales price reflects the fair market value on Friday, October 31, 2025.
Thermon Group Holdings director Angela Strzelecki received 1,008 shares of Thermon common stock on 10/01/2025 at a reported price of $27.28 per share under the issuer's Non-Employee Director Compensation Program. After the award, Strzelecki beneficially owns 12,372 shares in a direct ownership form. The Form 4 was signed on 10/02/2025 by Ryan Tarkington as attorney-in-fact. The filing identifies Strzelecki as a director and confirms this transaction was reported as an acquisition of non-derivative securities.
Thermon Group Holdings insider report: Director Victor L. Richey Jr. received an award of 1,008 shares of Thermon Group Holdings, Inc. (ticker THR) under the company’s Non-Employee Director Compensation Program on 10/01/2025 at a reported price of $27.28 per share. After the award, the filing shows Mr. Richey beneficially owns 6,781 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing documents a routine director equity award and updates the director’s post-transaction beneficial ownership.
Thermon Group Holdings, Inc. (THR): This Form 4 reports that director George Marcus J was granted 1,008 shares of the issuer's common stock on 10/01/2025 under the companys Non-Employee Director Compensation Program. The shares were awarded at a reported price of $27.28 per share, and following the award Mr. Marcus beneficially owns 51,368 shares in a direct ownership form. The filing is signed by an attorney-in-fact on behalf of the reporting person on 10/02/2025. The document contains no other transactions, derivatives, or additional explanatory detail.
Thermon Group Holdings, Inc. (THR) reported a Form 4 showing a director-level insider award under the company’s Non-Employee Director Compensation Program. On 10/01/2025 Roger L. Fix was granted 1,008 shares of Common Stock at an indicated price of $27.28 per share. After the award, Mr. Fix is reported to beneficially own 34,104 shares of THR. The filing identifies Mr. Fix as a director and was signed on behalf of the reporting person by an attorney-in-fact on 10/02/2025. The Form 4 shows a routine equity award to a non-employee director and does not disclose option exercises, derivative positions, or additional material transactions.
Linda Dalgetty, a director of Thermon Group Holdings, Inc. (THR), received an award of 1,008 shares as director compensation on 10/01/2025. The shares were acquired at a reported price of $27.28 per share under the issuer's Non-Employee Director Compensation Program. After the award, Ms. Dalgetty beneficially owns 33,313 shares. The Form 4 was filed as a single reporting person and signed by an attorney-in-fact on 10/02/2025.
John U. Clarke, a director of Thermon Group Holdings, Inc. (THR), received 1,008 shares of Common Stock as an award under the company's Non-Employee Director Compensation Program on 10/01/2025 at a reported price of $27.28 per share. After the transaction, Mr. Clarke is reported to beneficially own 40,299 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact, Ryan Tarkington, on 10/02/2025. The filing documents the routine grant to a director and lists no derivative transactions or additional conditions in the reported sections.